A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 12, 2004, Pages 6340-6347

  Agoulnik, Irina U ^a   Tong, Xiao Wen ^g   Fischer, Dagmar C ^e   Körner, Klaus ^b   Atkinson, Neely E ^c   Edwards, Dean P ^d   Headon, Denis R ^f   Weigel, Nancy L ^a   Kieback, Dirk G ^a,e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Red Cross Blood Bank   (Germany)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f RICE UNIVERSITY   (United States)

^g TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROGESTERONE RECEPTOR;

AFRICAN AMERICAN; ARTICLE; CANCER RISK; CAUCASIAN; CHINA; COMPARATIVE STUDY; DISSOCIATION; FEMALE; GENE ACTIVATION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC RISK; GERMANY; HAPLOTYPE; HISPANIC; HORMONE BINDING; HUMAN; INTRON; NUCLEOTIDE SEQUENCE; OVARY CANCER; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR GENE; TRANSCRIPTION INITIATION;

ANIMALS; BINDING, COMPETITIVE; CERCOPITHECUS AETHIOPS; COS CELLS; DNA TRANSPOSABLE ELEMENTS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HORMONES; HUMANS; INTRONS; OSMOLAR CONCENTRATION; OVARIAN NEOPLASMS; RECEPTORS, PROGESTERONE; TRANSCRIPTION, GENETIC; TRANSFECTION;

INSERTION SEQUENCES;

EID: 10344234708     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0114     Document Type: Article

References (36)

1. American Cancer Society 2003 Cancer facts and figures. Atlanta: American Cancer Society
2. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH 1994 A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71
3. Monteiro AN 2000 BRCA1: exploring the links to transcription. Trends Biochem Sci 25:469-474
4. Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Zhang H, Wu GS, Licht JD, Weber BL, El-Deiry WS 1997 Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature 389:187-190
5. Conneely OM, Mulac-Jericevic B, DeMayo F, Lydon JP, O'Malley BW 2002 Reproductive functions of progesterone receptors. Recent Prog Horm Res 57:339-355
6. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CAJ, Shyamala G, Conneely OM, O'Malley BW 1995 Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 9:2266-2278
7. Mulac-Jericevic B, Mullinax RA, DeMayo FJ, Lydon JP, Conneely OM 2000 Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 289:1751-1754
8. Mulac-Jericevic B, Lydon JP, DeMayo FJ, Conneely OM 2003 Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc Natl Acad Sci USA 100:9744-9749
9. Loutradis D, Bletsa R, Aravantinos L, Kallianidis K, Michalas S, Psychoyos A 1991 Preovulatory effects of the progesterone antagonist mifepristone (RU486) in mice. Hum Reprod 6:1238-1240
10. Lau KM, Mok SC, Ho SM 1999 Expression of human estrogen receptor-α and -β, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. Proc Natl Acad Sci USA 96:5722-5727
11. Lydon JP, Ge G, Kittrell FS, Medina D, O'Malley BW 1999 Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res 59:4276-4284
12. Medina D, Kittrell FS, Shepard A, Contreras A, Rosen JM, Lydon J 2003 Hormone dependence in premalignant mammary progression. Cancer Res 63:1067-1072
13. Goepfert TM, McCarthy M, Kittrell FS, Stephens C, Ullrich RL, Brinkley BR, Medina D 2000 Progesterone facilitates chromosome instability (aneuploidy) in p53 null normal mammary epithelial cells. FASEB J 14:2221-2229
14. Fuqua SA, Hill SM, Chamness GC, Benedix MG, Greene GL, O'Malley BW, McGuire WL 1991 Progesterone receptor gene restriction fragment length polymorphisms in human breast tumors. J Natl Cancer Inst 83:1157-1160
15. McKenna NJ, Kieback DG, Carney DN, Fanning M, McLinden J, Headon DR 1995 A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma. Br J Cancer 71:451-455
16. Rowe SM, Coughlan SJ, McKenna NJ, Garrett E, Kieback DG, Carney DN, Headon DR 1995 Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion. Cancer Res 55:2743-2745
17. De Vivo I, Huggins GS, Hankinson SE, Lescault PJ, Boezenk M, Colditz GA, Hunter DJ 2002 A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. Proc Natl Acad Sci USA 99:12263-12268
18. Tetel MJ, Jung S, Carbajo P, Ladtkow T, Skafar DF, Edwards DP 1997 Hinge and amino-terminal sequences contribute to solution dimerization of human progesterone receptor. Mol Endocrinol 11:1114-1128
19. Jackson TA, Richer JK, Bain DL, Takimoto GS, Tung L, Horwitz KB 1997 The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol Endocrinol 11:693-705
20. Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW, McDonnell DP 1993 Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol 7:1244-1255
21. Allgood VE, Oakley RH, Cidlowski JA 1993 Modulation by vitamin B6 of glucocorticoid receptor-mediated gene expression requires transcription factors in addition to the glucocorticoid receptor. J Biol Chem 268:20870-20876
22. Wright D, Manos M 1990 Sample preparation from paraffin-embedded tissues. San Diego: Academic Press
23. Weir BS 1990 Genetic data analysis, 71-80 ed. Sunderland, MA: Sinaur Associates
24. Nazareth LV, Stenoien DL, Bingman III WE, James AJ, Wu C, Zhang Y, Edwards DP, Mancini M, Marcelli M, Lamb DJ, Weigel NL 1999 A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1). Mol Endocrinol 13:2065-2075
25. Zhang Y, Bai W, Allgood VE, Weigel NL 1994 Multiple signaling pathways activate the chicken progesterone receptor. Mol Endocrinol 8:577-584
26. Press M, Spaulding B, Groshen S, Kaminsky D, Hagerty M, Sherman L, Christensen K, Edwards DP 2002 Comparison of different antibodies for detection of progesterone receptor in breast cancer. Steroids 67:799-813
27. Kieback DG, Tong X-W, Weigel NL, Agoulnik IU 1998 A genetic mutation in the progesterone receptor (PROGINS) leads to an increased risk of non-familial breast and ovarian cancer causing inadequate control of estrogen receptor driven proliferation. J Soc Gynecol Invest 5:40a
28. Grifa A, Piemontese MR, Melchionda S, Origone P, Zelante L, Coviello D, Fratta G, Dallapiccola B, Balestrazzi P, Ajmar F 1995 Screening of neurofibromatosis type 1 gene: identification of a large deletion and of an intronic variant. Clin Genet 47:281-284
29. NIH NCIM 1975 Third national cancer survey: incidence data. Oxford, UK: Oxford University Press
30. Muir C, Waterhouse J, Mack T, Powell J, Whelan S 1987 Cancer incidence in five continents. Vol. 5. No. 88. Lyon, France: International Agency for Research on Cancer
31. Devesa SS, Silverman DT, Young Jr JL, Pollack ES, Brown CC, Horm JW, Percy CL, Myers MH, McKay FW, Fraumeni Jr JF 1987 Cancer incidence and mortality trends among whites in the United States, 1947-1984. J Natl Cancer Inst 79:701-770
32. Zhou ZX, Lane MV, Kemppainen JA, French FS, Wilson EM 1995 Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol Endocrinol 9:208-218
33. Beral V, Banks E, Reeves G 2002 Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 360:942-944
34. De Vivo I, Hankinson SE, Colditz GA, Hunter DJ 2003 A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk. Cancer Res 63:5236-5238
35. Mullick A, Katzenellenbogen BS 1986 Progesterone receptor synthesis and degradation in MCF-7 human breast cancer cells as studied by dense amino acid incorporation. Evidence for a non-hormone binding receptor precursor. J Biol Chem 261:13236-13246
36. Takimoto GS, Hovland AR, Tasset DM, Melville MY, Tung L, Horwitz KB 1996 Role of phosphorylation on DNA binding and transcriptional functions of human progesterone receptors. J Biol Chem 271:13308-13316